Oxford BioDynamics PLC has announced a TR-1 notification of major holdings by Vulpes Investment Management Pte Ltd. The reason for notification is an acquisition or disposal of voting rights, as well as an event changing the breakdown of voting rights. Vulpes Investment Management Pte Ltd, based in Singapore, holds 9.51% of voting rights attached to shares, totaling 29,653,978 voting rights in the issuer. This marks a decrease from the previous position of 14.06% of voting rights. The threshold was crossed on 8th April 2024, with the issuer being notified on 25th April 2024.
The notification details the shareholder as Vulpes Testudo Fund and Vulpes Life Sciences Fund, both based in the Cayman Islands. The notification also confirms that the person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the issuer.
This TR-1 notification provides essential information about the change in voting rights within Oxford BioDynamics PLC, offering transparency about the holdings and the entities involved.